The 41st Annual Meeting of the Japanese Society for the Study of Xenobiotics (JSSX)【Ibaraki】

             

Event Details

  • Date:

ADMET / Pharmacokinetics / Tsukuba

The 41st Annual Meeting of the Japanese Society for the Study of Xenobiotics (JSSX) [Ibaraki / Tsukuba]

The 41st Annual Meeting of the Japanese Society for the Study of Xenobiotics (JSSX) is a scientific meeting for researchers and professionals involved in drug metabolism, pharmacokinetics, and ADMET sciences. The meeting will provide a forum for sharing the latest scientific advances and technological developments in areas including drug metabolism, transporters, modeling, microphysiological systems, artificial intelligence, spatial omics, and new therapeutic modalities.

Date
November 16 (Mon.)–19 (Thu.), 2026

Venue
Tsukuba International Congress Center

Chair
Takafumi Komori, Ph.D.

Theme
Shu-Ha-Ri/In-On-Out

Event Information

  • Date: November 16 (Mon.)–19 (Thu.), 2026
  • Venue: Tsukuba International Congress Center
  • Address: 2-20-3 Takezono, Tsukuba City, Ibaraki Prefecture 305-0032, Japan
  • Organizer: The Japanese Society for the Study of Xenobiotics (JSSX)
  • Related Event: The 18th JSSX Short Course, November 16, 2026

Meeting Information

  • Official Meeting Name: The 41st Annual Meeting of the Japanese Society for the Study of Xenobiotics
  • Chair: Takafumi Komori, Ph.D. (Biopharmaceutical Assessment, Deep Human Biology Learning, Eisai Co., Ltd.)
  • Meeting Theme: Shu-Ha-Ri/In-On-Out: New paradigm in ADMET sciences pioneering the unknown path of the future

Main Topics

  • Drug metabolism, pharmacokinetics, transporters, and toxicology
  • PBPK, PBBM, MIDD, and modeling and systems pharmacology
  • Microphysiological systems, iPS cells, NAMs, and in vivo models
  • Spatial omics, analytical technologies, imaging, artificial intelligence, and machine learning
  • Drug delivery systems, biopharmaceuticals, new therapeutic modalities, and quantitative technologies

Overview

The meeting will cover a broad range of ADMET sciences, including drug metabolism, pharmacokinetics, transporters, toxicology, drug delivery systems, and the assessment of biopharmaceuticals. The program will also address emerging research areas such as PBPK and MIDD, artificial intelligence and machine learning, microphysiological systems, new approach methodologies, spatial omics, and new therapeutic modalities. Researchers from academia, industry, and regulatory organizations will discuss innovative evaluation methods and scientific approaches that connect drug discovery with nonclinical and clinical development.

Related Program

The 18th JSSX Short Course will be held on November 16, 2026. The Annual Meeting program will begin after the conclusion of the Short Course on the same day.